Opportunities & Announcements

Find NIAID grant funding opportunity announcements (FOAs) and Notices of Special Interest (NOSIs) below. Subscribe for Email Updates. Also see NIAID Contract Solicitations or Find Funding Outside NIH.

160 Results
Title Activity Code Posting Date Expiration Date Sort descending
Notice of Special Interest (NOSI)—Administrative Supplements for Lyme Disease and other Tickborne Illnesses - NOT-AI-22-048 Supp April 27, 2022 May 24, 2022
Shared Personal Protective Equipment (PPE) Resources (S10 Clinical Trial Not Allowed)- PAR-21-257 S10 June 03, 2021 May 25, 2022
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRCs) (U54, Basic Experimental Studies Involving Humans Allowed)- RFA-NS-22-019 U54 February 15, 2022 May 25, 2022
Data Management and Coordinating Center (DMCC) for the Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Collaborative Research Centers (CRC) (U24 Basic Experimental Studies with Humans Required)- RFA-NS-22-020 U24 February 15, 2022 May 25, 2022
Notice of Special Interest (NOSI)—Administrative Supplements for NIAID Regional Biocontainment Laboratories (RBL) and other NIH Grantees Conducting Research at RBL-affiliated Sites- NOT-AI-22-049 Supp May 04, 2022 June 01, 2022
Partnerships for Rapid Diagnostics and Phenotypic Antibacterial Susceptibility Testing for Bacteremia or Hospital Acquired Pneumonia (R01 Clinical Trial Not Allowed)- RFA-AI-22-010 R01 February 23, 2022 June 02, 2022
Asthma and Allergic Diseases Cooperative Research Centers (U19 Clinical Trial Optional)- RFA-AI-21-079 U19 December 23, 2021 June 04, 2022
Biomarker Signatures of TB Infection in Young Children With and Without HIV (R01 Clinical Trial Not Allowed)- RFA-AI-22-015 R01 February 09, 2022 June 09, 2022
Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)- PAR-22-078 Si2/R00 January 26, 2022 June 25, 2022
Immune Drivers of Autoimmune Disease (IDAD) (U01 Clinical Trial Not Allowed)- RFA-AI-22-012 U01 February 24, 2022 July 02, 2022
Development and Optimization of Next-Generation Immunological Assays to Support Influenza Clinical Studies and Trials (UH2/UH3 Clinical Trial Not Allowed)- RFA-AI-22-020 UH2/UH3 April 05, 2022 July 02, 2022
Notice of Special Interest—Administrative Supplements to Advance Precision Medicine Using the All of Us Research Programs Data- NOT-PM-22-002 Supp May 20, 2022 July 06, 2022
Improved Drug Susceptibility Testing (DST) for Tuberculosis (R01 Clinical Trial Not Allowed)- RFA-AI-22-016 R01 March 02, 2022 July 09, 2022
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)- PAR-20-153 R25 April 08, 2022 July 14, 2022
NIH Science Education Partnership Award (SEPA) (R25 - Clinical Trial Not Allowed)- PAR-20-153 March 30, 2020 July 14, 2022
Limited Competition Emergency Awards—Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed)- PAR-21-276 S10 July 16, 2021 July 16, 2022
Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-106 P30 February 03, 2020 July 29, 2022
Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)- PAR-20-107 P30 February 03, 2020 July 29, 2022
Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)- PAR-20-158 R01 March 31, 2020 July 29, 2022
Partnerships for the Development of Novel Therapeutics to Combat Select Antibiotic Resistant Bacteria and Fungi (R01 Clinical Trial Not Allowed)- RFA-AI-22-028 R01 April 05, 2022 July 30, 2022
Development of HIV Broadly Neutralizing Antibody Susceptibility Assays (R61/R33 Clinical Trial Not Allowed)- RFA-AI-22-022 R61/R33 March 10, 2022 August 04, 2022
Enhancing HIV Reservoir Susceptibility to Elimination (R01 Clinical Trial Not Allowed)- RFA-AI-22-025 R01 March 29, 2022 August 04, 2022
Limited Interaction Targeted Epidemiology—Viral Suppression (LITE-VS) (UG3/UH3 Clinical Trial Optional)- RFA-AI-22-024 UG3/UH3 April 13, 2022 August 04, 2022
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed)- PAR-20-108 R01 February 04, 2020 August 20, 2022
Getting To Zero—Understanding HIV Viral Suppression and Transmission in the United States (R01, Clinical Trial Optional)- PAR-20-036 R01 October 24, 2019 September 08, 2022